SEARCH

SEARCH BY CITATION

References

  • 1
    I. S. Kohane et al., “The Incidentalome: A Threat to Genomic Medicine,” JAMA 296, no. 2 (2006): 212215; E. S. Lander et al., “Initial Sequencing and Analysis of the Human Genome,”Nature 409, no. 6822 (2001): 860–921.
  • 2
    J. C. Venter et al., “The Sequence of the Human Genome,” Science 291, no. 5507 (2001): 13041351.
  • 3
    International Human Genome Consortium, “Finishing the Euchromatic Sequence of the Human Genome,” Nature 431, no. 7011 (2004): 931945.
  • 4
    E. Sugiyama et al., “Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism,” Journal of Clinical Oncology 25, no. 1 (2007): 3242.
  • 5
    S. M. Wolf et al., “Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations,” Journal of Law, Medicine & Ethics 36, no. 2 (2008): 219248.
  • 6
    Centers for Medicare and Medicaid Services, “Clinical Laboratory Improvement Amendments,” available at <http://www.cms.hhs.gov/CLIA/> (last visited December 30, 2007).
  • 7
    L. Turney, “The Incidental Discovery of Nonpaternity Through Genetic Carrier Screening: An Exploration of Lay Attitudes,” Qualitative Health Research 15, no. 5 (2005): 620634.
  • 8
    Unpublished observation of author (November 11, 2007).
  • 9
    D. I. Shalowitz and F. G. Miller, “Disclosing Individual Results of Clinical Research: Implications of Respect for Participants,” JAMA 294, no. 6 (2005): 737740.
  • 10
    See Kohane et al., supra note 1.
  • 11
    B. M. Knoppers et al., “The Emergence of an Ethical Duty to Disclose Genetic Research Results: International Perspectives,” European Journal of Human Genetics 14, no. 10 (2006): 11701178.
  • 12
    National Heart, Lung & Blood Institute (NHLBI), NHLBI Working Group on Reporting Genetic Results in Research Studies, Bethesda, MD, 2004, available at <http://www.nhlbi.nih.gov/meetings/workshops/gene-results.htm> (last visited November 11, 2007).
  • 13
    Id. .
  • 14
    Council for International Organization of Medical Sciences (CIOMS), International Guidelines for Biomedical Research Involving Human Subjects, Geneva, 2002, available at <http://www.cioms.ch/frame_guidelines-nov_2002.htm> (last visited November 11, 2007).
  • 15
    World Health Organization (WHO), Genetic Databases: Assessing the Benefits and the Impact on Human and Patient Rights, Geneva, 2003, available at <http://www.law.ed.uk/ahrb/publication/online/whofinalreport.doc> (last visited November 11, 2007).
  • 16
    Id. .
  • 17
    Consortium on Pharmacogenetics, Ethical and Regulatory Issues in Research and Clinical Practice, Minneapolis, 2002, available at <http://www.bioethics.umn.edu/News/pharm_report.pdf> (last visited November 11, 2007).
  • 18
    Id. .
  • 19
    Id. .
  • 20
    American Society of Human Genetics (ASHG), DNA Banking and DNA Analysis: Points to Consider, Bethesda, MD, 1998, available at <http://genetics.faseb.org/genetics/ashg/policy/pol-02.htm> (last visited November 11, 2007).
  • 21
    Canadian College of Medical Geneticists, “Policy Statement Concerning DNA Banking and Molecular Diagnosis,” Clinical Investigation of Medicine 14 (1991): 363365.
  • 22
    See Kohane et al., supra note 1.
  • 23
    Id. .
  • 24
    Id. .